The Russian government will create a temporary list of innovative drugs – the drugs, that will be a subject of state ...

The global cell therapy market is valued at $5.5 billion in 2025 and is projected to reach $12.2 billion by 2030, reflecting strong investment in manufacturing scale, allogeneic platforms, and ...

US–Dutch–Chinese biotech Harbour BioMed (HKEX: 02142) has extended its partnership with British pharma major AstraZeneca (LSE ...

The Russian drugmaker Akselpharm has successfully defended its patent for osimertinib the active ingredient of UK pharma ...

The US District Court for the District of Columbia has rejected Israel-headquartered Teva Pharmaceuticals Industries’ challenge to the Medicare Drug Price Negotiation Program - marking the 16th defeat ...

US biotech major Biogen and privately-held Dayra Therapeutics have announced a research collaboration to discover and develop ...

Germany’s STADA Arzneimittel has received marketing authorizations from the European Commission (EC) for its Kefdensis and ...

Privately-held Italian drugmaker Angelini Pharma has breached the Code of Practice for the Association of the British ...

Shares Danish pharma major Novo Nordisk were down 9.5% at 275.80 kroner today, after it announced disappointing top-line ...

Germany’s Bayer has announced positive topline results from the global Phase III study OCEANIC-STROKE, with its investigational, once daily, oral FXIa inhibitor asundexian.

US pharma major Johnson & Johnson (NYSE: JNJ) has halted its Phase IIb AuTonomy study after posdinemab failed to achieve a ...

The Danish government’s push to let citizens buy medicines from countries outside the EU is drawing sharp criticism from Lif, ...